Cargando…
Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment
Primary campylobacter enteritis with secondary bacteremia was diagnosed in an immunocompromised patient with stage IV gliosarcoma. She developed mild diarrhea followed by systemic symptoms with transient generalized weakness and fever. She was treated with azithromycin and had a full recovery and wi...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714086/ https://www.ncbi.nlm.nih.gov/pubmed/23882353 http://dx.doi.org/10.3402/jchimp.v2i1.17217 |
_version_ | 1782476614272024576 |
---|---|
author | Liu, Ping |
author_facet | Liu, Ping |
author_sort | Liu, Ping |
collection | PubMed |
description | Primary campylobacter enteritis with secondary bacteremia was diagnosed in an immunocompromised patient with stage IV gliosarcoma. She developed mild diarrhea followed by systemic symptoms with transient generalized weakness and fever. She was treated with azithromycin and had a full recovery and without relapse through 2 months of follow-up. Her diagnosis was confirmed by a positive stool culture for Campylobacter sp. and blood culture for Campylobacter jejuni/coli. |
format | Online Article Text |
id | pubmed-3714086 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Co-Action Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-37140862013-07-23 Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment Liu, Ping J Community Hosp Intern Med Perspect Case Report Primary campylobacter enteritis with secondary bacteremia was diagnosed in an immunocompromised patient with stage IV gliosarcoma. She developed mild diarrhea followed by systemic symptoms with transient generalized weakness and fever. She was treated with azithromycin and had a full recovery and without relapse through 2 months of follow-up. Her diagnosis was confirmed by a positive stool culture for Campylobacter sp. and blood culture for Campylobacter jejuni/coli. Co-Action Publishing 2012-04-30 /pmc/articles/PMC3714086/ /pubmed/23882353 http://dx.doi.org/10.3402/jchimp.v2i1.17217 Text en © 2012 Ping Liu http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Liu, Ping Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment |
title | Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment |
title_full | Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment |
title_fullStr | Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment |
title_full_unstemmed | Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment |
title_short | Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment |
title_sort | campylobacteremia in stage iv gliosarcoma with bevacizumab treatment |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714086/ https://www.ncbi.nlm.nih.gov/pubmed/23882353 http://dx.doi.org/10.3402/jchimp.v2i1.17217 |
work_keys_str_mv | AT liuping campylobacteremiainstageivgliosarcomawithbevacizumabtreatment |